跳至主要内容
临床试验/NCT00977275
NCT00977275已完成1 期

The Treatment of T1N0 Invasive Breast Carcinoma by Local Excision and Interstitial Implant

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 1997年6月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
45
试验地点
2
主要终点
To determine if interstitial implant brachytherapy to radical radiation doses is feasible following wide local excision of T1N0 breast carcinoma

研究概览

简要总结

The purpose of this study is to evaluate radiation therapy directed to a small region of the breast in women who were recently diagnosed with early stage invasive breast cancer.

详细描述

  • When participants undergo surgery to remove the tumor (lumpectomy), it will be followed by the placement of small flexible tubes throughout the region surrounding the site of operation. These tubes will remain in place for 7-9 days following the surgery.
  • The first 2-3 days, the tubes will not contain radioactivity. This time is used to do all the calculations necessary for treatment and to check the findings in the breast tissue that was removed. After 2-3 days, the tubes will be filled with a radioactive wire which will remain in place for the next 5 days. During this period of time, participants will be required to remain within the hospital. At the end of these 5 days, the radioactive wires and tubes will be removed.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Low risk of multifocal disease within the breast whose tumor location is favorable for brachytherapy catheter placement
  • Diagnosis of invasive breast carcinoma (biopsy or fine needle aspiration cytology) and be clinical stage T1N0 (primary tumor < 2cm, clinically negative nodes)
  • Location of primary tumor is not immediately adjacent to the nipple of chest wall
  • No evidence of two or more separate tumors within the breast
  • All histologic types and pathologic grades of primary tumor
  • No extensive intraductal component (substantial intraductal carcinoma away from the primary tumor location)
  • No lymphatic or vascular invasion
  • Lymph node staging by sentinel node excision or axillary dissection confirms node negative status (If node positive, implant is used to deliver boost to tumor bed)
  • Assessment of final surgical margins should be predominantly negative, but a single small region of focal positivity is allowable as it is for whole breast radiation
  • 18 years of age or older

排除标准

  • Tumor is too close to the chest wall to allow placement of catheters
  • Contraindications to radiation therapy are present, including a history of scleroderma, systemic lupus or other active connective tissue disease, pregnancy, or prior chest wall radiation

结局指标

主要结局

To determine if interstitial implant brachytherapy to radical radiation doses is feasible following wide local excision of T1N0 breast carcinoma

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alphonse Taghian, MD, PhD

Chief Breast Radiation Oncology, MGH

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验